On June 7, 2018, Shanghai Longyao Biology and Beijing Ciji Network signed a strategic cooperation agreement.
In view of Shanghai Longyao Bio’s research and development advantages, technological transformation advantages and product advantages in the field of immune cell therapy and stem cells; in view of Beijing Ciji’s advantages in medical resources, policy resources, medical clinic network resources, etc. (including Dr. Han Medical Clinic, Ciming Boao International Hospital and Ciming Physical Examination Group), the two parties will cooperate to establish a cell therapy research center in Party B's hospital to carry out tumor immune cell therapy.
Ye Shengqin, chairman of Shanghai Longyao Biotechnology Co., Ltd., and Han Xiaohong, founder and president of Ciming Health Checkup Group Co., Ltd., chairman of Beijing Ciji Network Technology Co., Ltd., and Hainan Boao Ciming International Hospital Co., Ltd. Han Xiaohong attended the signing ceremony. Dr. Hu Xiang, Chairman of Biotechnology Co., Ltd. witnessed the signing.
Ye Shengqin, Chairman of Longyao Biotechnology
Strategic Cooperation Signing Ceremony
Through this cooperation signing ceremony, the leaders of both parties expressed that the two companies will carry out in-depth cooperation in the future, and work hand in hand to devote themselves to the cause of biomedicine, biological anti-aging, and resource sharing, so as to achieve a new situation of creating a win-win situation.